UK backs Lucentis for new use after Novartis cuts price

LONDON (Reuters) – Britain’s healthcare cost watchdog has given its backing to eye drug Lucentis to treat diabetes-related problems after Swiss drugmaker Novartis offered it at a discount to the National Health Service. The National Institute for Health and Clinical Excellence (NICE), in a reversal of an earlier decision, said on Friday Lucentis should now be available for patients with diabetic macular oedema (DMO). Lucentis is already approved by NICE to treat wet age-related macular degeneration. …

Government to review cosmetic surgery industry

A nurse displays a cleaned defective silicone gel breast implant, manufactured by French company Poly Implant Prothese after being removed from a patient in NiceLONDON (Reuters) – The Department of Health has launched a review of the cosmetic surgery industry, which could lead to tighter restrictions on the way companies operate and market their services in the wake of the PIP breast implant scandal. The Department of Health said on Wednesday that Bruce Keogh, medical director of the National Health Service, would lead a team that will gather evidence and make recommendations to the government by March. …

UK to review cosmetic surgery industry

Defective silicone gel breast implants, manufactured by French company Poly Implant Prothese, is seen near surgical instruments after being removed from a patient in NiceLONDON (Reuters) – Britain has launched a review of the cosmetic surgery industry, which could lead to tighter restrictions on the way companies operate and market their services in the wake of the PIP breast implant scandal. The Department of Health said on Wednesday that Bruce Keogh, medical director of the National Health Service, would lead a team that will gather evidence and make recommendations to the government by March. …